319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine

• Gabriel Nistor,
• Robert Dillman,
• Daniela Bota,
• David Piccioni,
• Christopher Duma,
• Renato LaRocca,
• Santosh Kesari,
• Jose Carrillo,
• Robert O’Donnell,
• Robert Aiken,
• Frank Hsu,
• Xiao-Tang Kong,
• Thomas Taylor

Affiliations

Gabriel Nistor

Aff7 Neostem OncologyLLC Irvine United States

Robert Dillman

Aff7 Neostem OncologyLLC Irvine United States

Daniela Bota

1Unviersity of California, Irvine, Orange, USA

David Piccioni

3UCSD, San Diego, CA, USA

Christopher Duma

4Hoag Hospital, Newport Beach, CA, USA

Renato LaRocca

5Norton Cancer Center, Louisville, KY, USA

Santosh Kesari

6John Wayne Cancer Institute, Santa Monica, California, USA

Jose Carrillo

6John Wayne Cancer Institute, Santa Monica, California, USA

Robert O’Donnell

7UCDavis, Davis, USA

Robert Aiken

8Rutgers, New Brunswick, NJ, USA

Frank Hsu

2UCI, Orange, USA

Xiao-Tang Kong

2UCI, Orange, USA

Thomas Taylor

2UCI, Orange, USA